Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 444 of 5804
-
New injection aims to ease Post-Surgery pain without Morphine's downsides
Symptom relief OngoingThe primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following abdominal surgery.
Phase: PHASE3 • Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Brain training breakthrough: new device aims to quiet PTSD
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if training with the Prism system can reduce PTSD symptoms in US military Veterans and civilians with PTSD. Prism is a form of neurofeedback training that uses EEG signals to promote self-regulation of brain function. The main question …
Phase: NA • Sponsor: Foundation for Atlanta Veterans Education and Research, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New ultrasound dye could stop unnecessary emergency surgeries for ovarian torsion
Diagnosis Recruiting nowAdnexal torsion is the rotation of the ovary around its vascular axis resulting, in the absence of treatment, ischemia that can lead to peritonitis by necrosis or impaired fertility. It is a gynecological emergency affecting 3% of women of childbearing age, including from adolesc…
Phase: PHASE3 • Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Genome-First approach could speed up rare disease diagnoses for kids
Knowledge-focused ENROLLING_BY_INVITATIONIndividually rare genetic diseases are collectively common, and affect many Canadian families. Making the right diagnosis is both important and challenging. Healthcare providers and families often remain in the dark for too long, limited by the scope and speed of current genetic …
Phase: NA • Sponsor: The Hospital for Sick Children • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New monthly shot aims to keep schizophrenia symptoms at bay
Disease control Recruiting nowThe purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Smart drug missiles take aim at Hard-to-Treat lung cancer
Disease control Recruiting nowResearchers are looking for new ways to treat metastatic nonsquamous non-small cell lung cancer (NSCLC) that has been treated before. Metastatic means the cancer has spread to other parts of the body. Nonsquamous means the cancer did not start in squamous cells, which are flat ce…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a simple drug stop deadly organ failure after surgery?
Prevention OngoingMajor abdominal surgeries (e.g., gastrectomy, pancreatectomy, colectomy) carry a high risk of life-threatening postoperative complications, including multiorgan disfunction syndrome (MODS), acute kidney injur (AKI), miocardial injury after non-cardiac surgery (MINS) and severe in…
Phase: PHASE3 • Sponsor: Botkin Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy targets aggressive lung cancer transformation
Disease control Recruiting nowThe primary treatment option for non-small cell lung cancer (NSCLC) adenocarcinoma (ADC) with activating epidermal growth factor receptor (EGFR) mutation is EGFR tyrosine kinase inhibitor (TKI). After a certain period of treatment with EGFR TKI, acquired resistance emerges most f…
Phase: PHASE2 • Sponsor: Se-Hoon Lee • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThe researchers are doing this study is to find out if lower doses (given in fewer treatments over a shorter period of time) of radiation therapy in combination with standard-of-care chemotherapy is an effective treatment for people with Human Papilloma Virus (HPV)-positive throa…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo aims to cut hormone therapy in prostate cancer
Disease control Recruiting nowThe goal of this clinical trial is to is to investigate if it is possible to lower the chance of cancer reoccurrence and also preserve quality of life by using the drug Pluvicto instead of androgen-deprivation therapy to the usual radiation therapy for advanced local prostate can…
Phase: PHASE1, PHASE2 • Sponsor: Angela Y. Jia, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for Hard-to-Treat colorectal cancer: drug combo enters Mid-Stage trial
Disease control Recruiting nowThis is a Phase II trial designed to determine the optimal dose and evaluate the effectiveness of TL938 and trastuzumab in treating patients with HER2+ colorectal cancer that has metastasized or recurred and is inoperable.
Phase: PHASE2 • Sponsor: Suzhou Teligene Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New CMV prevention drug could be safer for kidney transplant patients
Prevention Recruiting nowthe existing anti-CMV drugs mainly include valganciclovir, ganciclovir and foscarnet sodium, all of which act on DNA polymerase (pUL54), making them prone to cross resistance. DNA synthesis in normal cell is also catalyzed by DNA polymerase, which can also inhibit normal cell pro…
Phase: PHASE4 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
One-Patient trial hopes to fix rare nerve disease at its genetic root
Disease control OngoingThis is an 'N of 1', open-label, single center study to evaluate the safety of therapy with VCA-894A, an ASO designed to rescue and restore the activity of IGHMBP2, when administered by intrathecal injection.
Phase: PHASE1, PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a weekly shot help type 1 diabetes patients shed pounds and control blood sugar?
Disease control OngoingThe main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 20 months.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Blood test guides safer cancer treatment after surgery
Disease control Recruiting nowThis is a single institution phase II study that will enroll patients with T0-3N0-2 p16-positive oropharyngeal squamous cell carcinoma (OSCC) undergoing resection of all gross visible disease at the primary site and in the lymph nodes.
Phase: PHASE2 • Sponsor: Zachary Zumsteg • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New pill shows promise for PNH patients still anemic on standard therapy
Disease control CompletedThe purpose of this study is to evaluate the efficacy of HSK39297 tablets in paroxysmal nocturnal hemoglobinuria (PNH) patients with anemia after stable treatment of anti-C5 antibody.
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a drug combo save nerves in ear cancer surgery?
Disease control Recruiting nowTo evaluate the efficacy and safety of induction chemotherapy combined with tislelizumab as neoadjuvant therapy in patients with locally advanced squamous cell carcinoma of the external auditory canal; to explore the improvement in the preservation rate of important neurovascular…
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for severe aplastic anemia: bone marrow transplant from partial matches shows promise
Disease control Recruiting nowBMT CTN 2207 will investigate the use of marrow transplantation for treatment of severe aplastic anemia that has not previously been treated.
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for Crohn's sufferers: phase 3 drug trial launches
Disease control Recruiting nowThis Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New combo aims to turn inoperable stomach cancer into operable disease
Disease control Recruiting nowThis is a prospective, single-center, single-arm, open phase II clinical study. Forty-nine participants with pathologically or cytologically confirmed gastric cancer or gastroesophageal junction cancer are scheduled to be enrolled in this study. All participants will be treated w…
Phase: PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC